Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/1993
04/07/1993EP0535626A1 Use of 4-amino-1-(2-pyridyl)piperidines as anti-convulsivant and anti-epileptic agents
04/07/1993EP0535496A1 (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments
04/07/1993EP0535317A1 Drug for the treatment of agitation state and nerve dysfonction
04/07/1993EP0535111A1 Transdermal administration of buprenorphine
04/07/1993CN1070644A 3,4-dehydropiperidine derivatives
04/06/1993US5200531 Condensing alkoxyfuranone with benzaldehyde in mixture of dipolar aprotic solvent and protic solvent using lithium hydroxide catalyst, precipitating with water, removing solvent
04/06/1993US5200405 Use of n-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders
04/06/1993US5200198 Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals
04/06/1993CA1315791C Oxathiolanes
04/06/1993CA1315790C Method of improving sleep
04/06/1993CA1315786C Imidazoquinoxaline compounds and their preparation and use
04/06/1993CA1315784C Heteroaryloxy-.beta.-carboline derivatives, their preparation and their use as medicinal agents
04/06/1993CA1315691C Therapeutic agents containing enantiomers of propafenone
04/06/1993CA1315690C Synergistic combination of decarboxylase inhibitors and l-dopa pellets
04/06/1993CA1315687C Dosage form for dispensing drug for human therapy
04/06/1993CA1315678C Alpha-tocopherol based vesicles
04/05/1993CA2079642A1 Medicament
04/01/1993WO1993006116A1 Glial derived neurotrophic factor
04/01/1993WO1993006105A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
04/01/1993WO1993006103A1 Triazoloquinoxalin-1,4-diones and their preparation and use
04/01/1993WO1993006101A1 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2a]PYRAZINES
04/01/1993WO1993006099A1 Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
04/01/1993WO1993006098A1 Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them
04/01/1993WO1993006084A1 Benzanilide derivatives as 5-ht1d antagonists
04/01/1993WO1993005800A1 Method and compositions for the treatment of cerebral palsy
04/01/1993WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
04/01/1993WO1993005786A1 Novel gabaa receptor with steroid binding sites
04/01/1993WO1993005783A1 Diagnosis and therapy for parkinson's disease
04/01/1993WO1993005779A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
04/01/1993WO1993003148A3 Tau/neurofilament protein kinases pk40 and pk36
04/01/1993CA2119579A1 Heterocyclic compounds and their preparation and use
04/01/1993CA2118938A1 Novel gabaa receptor with steroid binding sites
04/01/1993CA2118936A1 Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
04/01/1993CA2116130A1 Diagnosis and therapy for parkinson's disease
03/1993
03/31/1993EP0534904A1 Imidazolylmethyl-pyridines
03/31/1993EP0534856A1 Oxime ethers of thienocyclopentanones, their preparation and pharmaceutical compositions containing them
03/31/1993EP0534844A1 New derivatives of decahydroquinoline, process for their preparation, intermediaires of the preparation, their use as medicines and compositions containing them
03/31/1993EP0534814A1 Process for the preparation of a dextrorotatory isomer of isoindoline derivative
03/31/1993EP0534756A2 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy)propylamines as norepinephrine uptake inhibiteurs
03/31/1993EP0534667A1 Tricyclic heterocycles as PGE2 antagonists
03/31/1993EP0534628A1 Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone, and their use
03/31/1993EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE
03/31/1993EP0534423A1 14-Hydroxy-N-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, process for their preparation and their use as medicines
03/31/1993EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0534363A2 Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
03/31/1993EP0534344A1 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines, a process for their preparation and their use as modulators of neurotransmitter function
03/31/1993EP0534343A1 Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
03/31/1993EP0533920A1 THIOPYRANO 2,3-b]INDOLE DERIVATIVE
03/31/1993EP0533878A1 Isoxazolyl imidazole derivatives, process for producing them and their use in medicaments
03/31/1993EP0533846A1 The ciliary neurotrophic factor receptor
03/31/1993EP0533832A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
03/31/1993EP0533804A1 Sigma binding site agents
03/31/1993EP0309526B1 Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
03/31/1993CN1070403A betaarboline derivatives and process for preparing same and use in pharmaceuticals
03/31/1993CA2079361A1 Use of 4-amino-1-(2-pyridyl)piperidines as anti-convulsant and antiepileptic agents
03/30/1993US5198451 Heterocyclic carboxylic acids
03/30/1993US5198450 Phenylalkanoylamine derivatives, process for preparing the same, and usage of the same
03/30/1993US5198438 Angiotensin ii antagonists incorporating a substituted thiophene or furan
03/30/1993CA1315477C 2-amino acetamide derivatives
03/30/1993CA1315473C 4-piperidinecarboxamide derivatives
03/30/1993CA1315283C Tricyclic amines derived from tetrahydro-5,6,7,8, naphto ¬2,3b| dihydro-2,3-furane and tetrahydro-6,7,8,9-5h benzocyclohepta(2,3b) dihydro-2,3-furane, processes for their preparation and pharmaceutical compositions holding same
03/30/1993CA1315202C Oral sustained release acetaminophen formulation and process
03/28/1993CA2079185A1 Dicyclic nitrogens derivatives, preparation process thereof and pharmaceutical compositions containing them
03/28/1993CA2079162A1 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy) propylamines
03/28/1993CA2079153A1 14-hydroxy-n-(2-methoxyethyl)-7, 8-dihydromorphine and - norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositions
03/28/1993CA2078401A1 Tricyclic heterocycles
03/26/1993CA2079016A1 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them
03/24/1993EP0533516A2 Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them
03/24/1993EP0533280A1 Novel medical use for tachykinin antagonists
03/24/1993EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993EP0533267A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993EP0533266A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993EP0533210A1 Protein C containing pharmaceutical preparations
03/24/1993EP0533209A1 beta-sympathomimetic Protein C containing pharmaceutical preparation
03/24/1993EP0532752A1 Compound tan-1251, its derivatives, their production and use
03/24/1993EP0532642A1 Substituted guanidines having high binding to the sigma receptor and the use thereof
03/24/1993EP0532602A1 Benzothiazoline derivatives, process for their preparation and drugs containing same.
03/24/1993EP0532545A1 Nicotinylalanine as a therapeutic agent acting on the central nervous system
03/24/1993EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals
03/23/1993US5196454 Method of treating disorders of the dopaminergic systems using 2,5-diaminotetralines
03/23/1993US5196434 Antidepressants, anxiolytic agents
03/23/1993US5196315 Human neuronal cell line
03/23/1993CA1314885C Tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present
03/23/1993CA1314881C Anti-anxiety agents
03/23/1993CA1314879C Anellated indole derivatives
03/19/1993CA2078507A1 Benzanilide derivatives
03/19/1993CA2078506A1 Benzanilide derivatives
03/19/1993CA2078505A1 Benzanilide derivatives
03/18/1993WO1993005043A1 Novel isatinoxime derivatives, their preparation and use
03/18/1993WO1993005041A1 Method for preparing the dextrorotatory isomer of an isoindolinone derivative
03/18/1993WO1993005038A1 5-ht4 receptor antagonists
03/18/1993WO1993005031A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
03/18/1993WO1993005012A1 New compounds
03/18/1993WO1993004688A1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist
03/18/1993WO1993004686A1 Chemical compounds
03/18/1993WO1993004685A1 Antidepressant polycyclic imides
03/18/1993WO1993004682A1 Novel 4-arylpiperazines and 4-arylpiperidines
03/18/1993WO1993004681A1 Use of antagonists or partial agonists on the 5-ht1a receptor for the treatment and prevention of cognitive disorders
03/18/1993WO1993004676A1 High content ibuprofen agglomerates and process to prepare them
03/18/1993WO1993004675A1 Composition comprising a tramadol material and acetaminophen and its use
1 ... 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 ... 1833